NICE rejects NHS funding for Kyowa Kirin's Poteligeo

30th July 2020 Uncategorised 0

NICE is not recommending NHS funding for Kyowa Kirin’s Poteligeo (mogamulizumab) as a treatment for mycosis fungoides or Sézary syndrome for adults who have had at least one previous systemic treatment.

More: NICE rejects NHS funding for Kyowa Kirin's Poteligeo
Source: News